BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7541324)

  • 21. [Subclinical hepatocellular carcinoma].
    Tang ZY
    Zhonghua Zhong Liu Za Zhi; 1983 May; 5(3):226-8. PubMed ID: 6194949
    [No Abstract]   [Full Text] [Related]  

  • 22. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].
    Department of Medical Administration, National Health and Health Commission of the People's Republic of China
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):112-128. PubMed ID: 32164061
    [No Abstract]   [Full Text] [Related]  

  • 24. A new concept on the natural course of hepatocellular carcinoma.
    Tang ZY
    Chin Med J (Engl); 1981 Sep; 94(9):585-8. PubMed ID: 6169492
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for hepatocellular carcinoma with cirrhosis: the initial experience and a preliminary report from the University of Ghent, Belgium.
    Troisi R; Praet M; Defreyne L; Elewaut A; Hesse UJ; Pattyn P; Decruyenaere J; De Hemptinne B
    Transplant Proc; 1994 Dec; 26(6):3570-1. PubMed ID: 7527980
    [No Abstract]   [Full Text] [Related]  

  • 27. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
    Aoyagi Y; Yanagi M; Asakura H
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
    [No Abstract]   [Full Text] [Related]  

  • 28. [Liver transplantation for hepatocellular carcinoma].
    Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oesophageal metastases of hepatocellular carcinoma after liver transplantation.
    Kahn J; Kniepeiss D; Langner C; Wagner D; Iberer F; Tscheliessnigg K
    Transpl Int; 2010 Apr; 23(4):438-9. PubMed ID: 19761554
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening and treatment for hepatocellular carcinoma.
    Sherman M; Takayama Y
    Gastroenterol Clin North Am; 2004 Sep; 33(3):671-91, xi. PubMed ID: 15324950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assay of alpha-fetoprotein by monoclonal antibodies: progress in the diagnosis of hepatocellular carcinoma?].
    Bergman JF; Labadie H; Beaugrand M
    Gastroenterol Clin Biol; 1985 Oct; 9(10):742. PubMed ID: 2415422
    [No Abstract]   [Full Text] [Related]  

  • 33. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
    Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
    [No Abstract]   [Full Text] [Related]  

  • 34. Downstaging hepatocellular carcinoma prior to liver transplantation.
    Gamblin TC; Geller DA
    Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
    [No Abstract]   [Full Text] [Related]  

  • 35. [Practical screening and early treatment of hepatocellular carcinoma. Results of a French survey].
    Ganne-CarriƩ N; Chevret S; Barbare JC; Chaffaud C; Grando V; Vogt AM; Beaugrand M; Trinchet JC;
    Gastroenterol Clin Biol; 2002; 26(6-7):570-7. PubMed ID: 12193855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of allogenic hematopoietic stem cell transplantation on tumor recurrence and metastasis of hepatocellular carcinoma after hepatectomy and the relationship with presence of AFP mRNA and VEGF-C mRNA in peripheral blood].
    Deng ZG; Li B; Zu C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):256-60. PubMed ID: 20506647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Hepatocellular Carcinoma.
    Frenette C
    Clin Liver Dis; 2020 Nov; 24(4):xiii-xiv. PubMed ID: 33012459
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma (primary cancer of the liver).
    Barbare JC; Boige V; Boudjema K; Lescesne R; Trinchet JC
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S57-2S61. PubMed ID: 17151564
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Jelic S; Sotiropoulos GC;
    Ann Oncol; 2010 May; 21 Suppl 5():v59-64. PubMed ID: 20555104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.